Breakdown of the gut barrier in patients with multiple organ dysfunction syndrome is attenuated by continuous blood purification: Effects on tight junction structural proteins

International Journal of Artificial Organs

Volumn 33, Issue 1, 2010, Pages 5-14

  Zhang, Jian Bin ^a   Du, Xiao Gang ^a   Zhang, Hui ^a   Li, Man Li ^a   Xiao, Gang ^a   Wu, Jiang ^a   Gan, Hua ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Continuous venovenous hemofiltration; iNOS; Intestinal permeability; Multiple organ dysfunction syndrome; Occludin; ZO 1

Indexed keywords

BLOOD; GLUCOSE; MONOLAYERS; PATIENT TREATMENT; POLYMERASE CHAIN REACTION; PROTEINS; PURIFICATION;

BLOOD PURIFICATION; CONTINUOUS VENOVENOUS HEMOFILTRATION; GUT BARRIER; HEMOFILTRATION; INDUCIBLE NITRIC OXIDE SYNTHASE; INTESTINAL PERMEABILITIES; MULTIPLE ORGAN DYSFUNCTION SYNDROME; OCCLUDIN; ZONULA OCCLUDEN-1; ZONULA OCCLUDENS;

NITRIC OXIDE;

AMINE OXIDASE (COPPER CONTAINING); ENDOTOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OCCLUDIN; PROTEIN ZO1; STRUCTURAL PROTEIN;

APACHE; ARTICLE; CELL STRAIN CACO 2; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME BLOOD LEVEL; GASTROINTESTINAL MUCOSA; GENE EXPRESSION REGULATION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MONOLAYER CULTURE; MULTIPLE ORGAN FAILURE; PERMEABILITY BARRIER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION;

EID: 77649246170     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003300102     Document Type: Article

References (24)

1. Leaphart CL, Tepas JJ 3rd. The gut is a motor of organ system dysfunction. Surgery 2007; 141: 563-9.
2. Velasco N. Gut barrier in the critically ill patient, facts and trends. Rev Med Chil 2006; 134 (8): 1033-9.
3. Cavrriani EA, Domingos HV, Soares AL, et al. Lymphatic system as a path underlying thespread of lung and gut injury after intestinal ischemia/reperfusion in rat. Shock 2005; 23: 330-6.
4. Li JY, Sun D, Lu Y, et al. Change in intestinal function in sepsis in rat. Zhong Guo Wei Zhong Bing Ji Jiu Yi Xue Za Zhi 2004; 16 (6): 352-4.
5. Haiyan Liu, Weiqin Li, Xinying Wang, et al. Early gut mucosal dysfunction in patients with qcute pancreatitis. Pancreas 2008; 36: 192-6.
6. Lin H, Gebhardt M, Bian S, et al. Enhancing effect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer. Int J Pharm 2007; 330: 23-31.
7. Blikslager AT, Moeser AJ, Gookin JL, et al. Restoration of barrier function in injured intestinal mucosa. Physiol Rev 2007; 87: 545-64.
8. Kucharzik T, Walsh SV, Chen J, et al. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001;159 (6): 2001-9.
9. Chen ML, Pothoulakis C, Turner JR, et al. Protein Kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to clostridium difficile toxin A. J Biol Chem 2002; 277: 4247-54.
10. Al-Sadi RM, Ma TY. IL-1 beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 2007; 178: 4641-9.
11. Chen Y, Liu Z, Chen Z, et al. Restoration of immune homeostasis in patients with SIRS/sepsis receiving continiuous blood purification therapy. Am J Soc Nephrol 2003; 14: 789A
12. Chen Z.-H, Liu Z.-H, YU C, et al. Endothelial dysfunction in patients with severe acute pancreatitis:Improved by continous blood purification therapy. Artificial Kidney and Dialysis 2007; 30: 393-400.
13. Hirotani Y, Ikeda K, Kato R, et al. Protective Effects of Lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells. Yakugaku Zasshi 2008; 128: 1363-8.
14. Ammori BJ, Leeder PC, King RF, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg 1999; 3: 252-62.
15. Paul S, Joseph E, Hamid R. Continuous dialysis as systemic therapy in the critically ill patient? Crit Care Med 2003; 31: 988-9.
16. Emre F, Yekebas MD, Claus F, et al. Attenuation of sepsisrelated immunoparalysis by continuous venovenous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001; 29: 1423-30.
17. Mitchell P, Fink MD. Intestinal epithelial hyperpermeability. Update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care 2003; 9: 143-51
18. Samonte VA, Goto M, Ravindranath TM, Fazal N, et al. Exacerbation of interstinal permeability in rats after a two hit injury: burn and Enterrococcus faecalis infection. Crit Care Med 2004; 32: 2267-73.
19. Han X, Fink MP, Delude RL. Proinflammatory cytokines cause NO-dependent and independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 2003; 19: 229-37
20. Han X, Fink MP, Yang R, Delude RL. Increased iNOS activity is essential for intestina1 epithelia1 tight junction dysfunction in endotoxemic mice. Shock 2004; 21: 261-70
21. Gobert AP, McGee DJ, Akhtar M, et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic dcells: a strategy for bacterial survival. Proc Natl Acad Sci USA 2001; 98: 13844-9.
22. Chavez A, Menconi MJ, Hodin RA, et al. Cytokine-induced epithelial hyperpermeability: role of nitric oxide. Crit Care Med 1999; 27: 2246-51.
23. Teraoka S, Mineshima M, Hoshino T, et al. Can cytokines be removed by hemofiltration or hemoadsorption? ASAIO J 2000; 46: 448-51.
24. Banan A, Fields JZ, Zhang Y, et al. iNOs upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol 2001; 280: G828-43.